AXichem AB (Sweden) Performance
| AXIC-A Stock | SEK 1.24 0.05 4.20% |
The firm shows a Beta (market volatility) of 0.14, which signifies not very significant fluctuations relative to the market. As returns on the market increase, AXichem AB's returns are expected to increase less than the market. However, during the bear market, the loss of holding AXichem AB is expected to be smaller as well. At this point, aXichem AB has a negative expected return of -0.0696%. Please make sure to confirm AXichem AB's information ratio, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to decide if aXichem AB performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days aXichem AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong forward indicators, AXichem AB is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 12 M | |
| Total Cashflows From Investing Activities | -4.7 M |
AXichem |
AXichem AB Relative Risk vs. Return Landscape
If you would invest 134.00 in aXichem AB on December 17, 2024 and sell it today you would lose (10.00) from holding aXichem AB or give up 7.46% of portfolio value over 90 days. aXichem AB is generating negative expected returns and assumes 3.5225% volatility on return distribution over the 90 days horizon. Simply put, 31% of stocks are less volatile than AXichem, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
AXichem AB Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AXichem AB's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as aXichem AB, and traders can use it to determine the average amount a AXichem AB's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0197
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AXIC-A |
Estimated Market Risk
| 3.52 actual daily | 31 69% of assets are more volatile |
Expected Return
| -0.07 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average AXichem AB is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AXichem AB by adding AXichem AB to a well-diversified portfolio.
AXichem AB Fundamentals Growth
AXichem Stock prices reflect investors' perceptions of the future prospects and financial health of AXichem AB, and AXichem AB fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AXichem Stock performance.
| Return On Equity | -0.36 | |||
| Return On Asset | -0.17 | |||
| Operating Margin | (7.35) % | |||
| Current Valuation | 224.35 M | |||
| Shares Outstanding | 16.54 M | |||
| Price To Earning | (26.98) X | |||
| Price To Book | 5.03 X | |||
| Price To Sales | 95.52 X | |||
| Revenue | 4.36 M | |||
| EBITDA | (12.58 M) | |||
| Cash And Equivalents | 39.34 M | |||
| Cash Per Share | 2.62 X | |||
| Total Debt | 164 K | |||
| Debt To Equity | 0.20 % | |||
| Book Value Per Share | 2.62 X | |||
| Cash Flow From Operations | (15.6 M) | |||
| Earnings Per Share | (0.94) X | |||
| Total Asset | 58.77 M | |||
| Retained Earnings | (9 M) | |||
| Current Asset | 5 M | |||
About AXichem AB Performance
By analyzing AXichem AB's fundamental ratios, stakeholders can gain valuable insights into AXichem AB's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AXichem AB has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AXichem AB has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
aXichem AB develops, patents, and markets natural-analogue industrial compounds for the marine, pest control, feed ingredient, and medical application markets in Sweden and internationally. It offers aXiphen-repellent, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables aXiphen-feed ingredient for pig and poultry diets and aXiphen for use in various foods and dietary supplements, as well as in the pharmaceutical industry. aXichem AB is traded on Stockholm Stock Exchange in Sweden.Things to note about aXichem AB performance evaluation
Checking the ongoing alerts about AXichem AB for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for aXichem AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| aXichem AB generated a negative expected return over the last 90 days | |
| aXichem AB may become a speculative penny stock | |
| aXichem AB has high historical volatility and very poor performance | |
| The company reported the revenue of 4.36 M. Net Loss for the year was (15.09 M) with profit before overhead, payroll, taxes, and interest of 909 K. | |
| aXichem AB has accumulated about 39.34 M in cash with (15.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.62, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 33.0% of the company shares are held by company insiders |
- Analyzing AXichem AB's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AXichem AB's stock is overvalued or undervalued compared to its peers.
- Examining AXichem AB's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AXichem AB's management team can have a significant impact on its success or failure. Reviewing the track record and experience of AXichem AB's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AXichem AB's stock. These opinions can provide insight into AXichem AB's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for AXichem Stock analysis
When running AXichem AB's price analysis, check to measure AXichem AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AXichem AB is operating at the current time. Most of AXichem AB's value examination focuses on studying past and present price action to predict the probability of AXichem AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AXichem AB's price. Additionally, you may evaluate how the addition of AXichem AB to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |